BioSpace News Archive

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, announced financial results for the second quarter ending June 30, 2020, and provided a business update.

Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced the introduction of Its AEM 2X enTouch® Scissors.

The Series A, led by a non-disclosed strategic investor, together with Hadean Ventures and Investinor, will fund CardioMech’s journey to treat patients in a first-in-human feasibility trial

Fennec Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development of PEDMARKTM for the prevention of platinum-induced ototoxicity in pediatric patients, reported its financial results for the second quarter ended June 30, 2020 and provided a business update.

United Therapeutics Corporation announced that Dr. Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company’s business during a fireside chat session at the Wedbush PacGrow Healthcare Virtual Conference.

The Cystic Fibrosis Foundation announced a collaboration with Longwood Fund, a biotech-focused venture capital firm, to accelerate innovative therapies for cystic fibrosis.

Generation Bio Co., an innovative genetic medicines company creating a new class of non-viral gene therapy, announced that management will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, Aug. 12, 2020 at 10:20 a.m. ET.

ViewRay, Inc. announced that Kaohsiung Medical University Chung-Ho Memorial Hospital in Kaohsiung City, Taiwan has begun patient treatments with the MRIdian® MR-Guided Radiation Therapy System, a cutting-edge device that delivers personalized cancer care by combining the latest innovations in precision radiation delivery with ground-breaking MR-guidance.

CVS Health Corporation announced operating results for the three months ended June 30, 2020.

Viela Bio, a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases, announced it will host a webcast and conference call on Wednesday, August 12, 2020 at 5:00 p.m. ET to discuss its second quarter 2020 financial results and program highlights.